Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification.
Circulating endothelial progenitor cells (EPCs) are reduced in patients with systemic lupus erythematosus (SLE). A reduced number of EPCs are associated with the presence of atherosclerosis in other populations. We sought to determine whether the reduction in EPC numbers in SLE is dependent on the presence of advanced coronary artery calcification (CAC). Patients with SLE had previous coronary calcium scores which placed them in either the >75th percentile or <25th percentile for their age. Seventeen patients with SLE and 13 healthy controls (HC) were included in the study. White blood cells were stained for EPC and progenitor cell markers including CD34, CD133, and VEGFR and analyzed by flow cytometry. SLE patients had repeated coronary imaging as well as carotid ultrasound. There was no difference in age between groups. SLE patients with advanced CAC were more likely to be hypertensive, to be smokers, and to have longer disease duration than SLE patients without CAC. SLE patients without evidence of CAC had a significantly lower number of EPCs (CD34+/CD133+/VEGFR+) compared to HC (median (IQR)) 0 (0, 6.7) vs. 10.2 (5.8, 12.3) (P = 0.02). Total numbers of PCs (CD133+/CD34+) were not significantly decreased in patients with SLE ((mean ± SEM) 1,007 ± 154 vs. 824 ± 170 (P = 0.20)). No significant difference was seen in EPC number between SLE patients without CAC and those with advanced CAC. Increased carotid intima-media thickness did not correlate with CAC or EPC number in SLE patients. Reduced numbers of EPCs in SLE patients may be observed compared to HC even in the absence of CAC. Differences in measured risk factor profiles and depletion of total circulating PCs do not fully explain this finding.
Division of Rheumatology, Department of Medicine, Hospital of the University of Pennsylvania, 8 Penn Tower Building, 34th and Civic Center Blvd., Philadelphia, PA 19104, USA. bakerjo@uphs.upenn.edu
Joshua F
JF
Baker
Lifeng
L
Zhang
Sotonye
S
Imadojemu
Alexis
A
Sharpe
Sarita
S
Patil
Jonni S
JS
Moore
Emile R
ER
Mohler
Joan
J
Von Feldt
D000328:Adult; D000368:Aged; D059168:Carotid Intima-Media Thickness; D003331:Coronary Vessels / Q000473:pathology*; D042783:Endothelial Cells / Q000473:pathology*; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013234:Stem Cells / Q000473:pathology*; D061205:Vascular Calcification / Q000097:blood* / Q000473:pathology
Science. 1997 Feb 14;275(5302):964-7
9020076
Rheumatol Int. 2010 Mar;30(5):591-8
19547978
Curr Vasc Pharmacol. 2010 Jul;8(4):437-49
19758114
N Engl J Med. 2005 Sep 8;353(10):999-1007
16148285
Ann Rheum Dis. 2007 Jul;66(7):865-70
17329307
Cytometry. 1999 Apr 15;38(2):78-80
10323221
Blood. 2007 Oct 15;110(8):2907-15
17638846
Circ Res. 2004 Aug 20;95(4):343-53
15321944
Rheumatol Int. 2011 Jun;31(6):773-8
20213291
Arthritis Rheum. 2007 May;56(5):1384-96
17469095
Cytometry B Clin Cytom. 2005 Mar;64(1):9-17
15668954
Cytometry B Clin Cytom. 2006 Mar;70(2):56-62
16456866
Cytometry B Clin Cytom. 2005 Mar;64(1):1-8
15668988
Am J Epidemiol. 2008 Nov 1;168(9):1016-23
18805900
Arthritis Rheum. 2009 Nov;60(11):3168-79
19877034
Arterioscler Thromb Vasc Biol. 2008 May;28(5):997-1004
18276910
Arthritis Rheum. 2006 Jul;54(7):2220-7
16802358
Rheumatology (Oxford). 2008 Oct;47(10):1476-83
18660509
J Hum Hypertens. 2007 Jun;21(6):445-51
17361211
Arthritis Res Ther. 2007;9(4):R84
17764548
Arthritis Rheum. 2007 Nov;56(11):3759-69
17968925
Clin Lab Med. 2007 Sep;27(3):453-68, v
17658402
Rheumatol Int. 2010 Sep;30(11):1429-36
19847436